Tag: M.W=250-300

Borer, Benedict; Kleyer, Hannah; Or, Dani published the artcile< Primary carbon sources and self-induced metabolic landscapes shape community structure in soil bacterial hotspots>, Application In Synthesis of 112-63-0, the main research area is soil carbon bacteria metabolism rhizosphere.

Direct observations of the complex and highly dynamic metabolic landscapes that affect the structure and functioning of bacterial communities in natural soil are limited by soil opacity and pore space complexity. In this study, we employ community metabolic network models to predict how the emerging bacterial community composition alters its structure and composition as a function of the primary carbon source in both well-mixed and spatially explicit systems. We provide systematic, exptl. validation using a synthetic community comprised of four bacterial species grown on prescribed carbon sources and quantify their abundance using qPCR. Results suggest that community members may benefit from trophic interactions or suffer from increased competitive stress depending on the carbon source. The modeling is expanded to consider interactions in soil-like spatial context. Results show emergence of distinct bacterial community compositions as a function of primary carbon sources typical to soil hotspots (carbohydrates or organic acids). The ability to link genetic information with bacterial community trophic interactions in representative soil environments is a critical first step towards attaining predictability of soil ecol. functioning.

Soil Biology & Biochemistry published new progress about Bacillus subtilis. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Application In Synthesis of 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Yang, Ke; Ma, Zhiyan; Tong, Hong-Xiao; Sun, Xiao-Qiang; Hu, Xiao-Yu; Li, Zheng-Yi published the artcile< Asymmetric Michael addition reactions catalyzed by a novel upper-rim functionalized calix[4]squaramide organocatalyst>, Related Products of 112-63-0, the main research area is chromenone preparation enantioselective; unsaturated carbonyl dicarbonyl Michael calixsquaramide organocatalyst; nitroalkane preparation enantioselective; aryl nitroolefin acetylacetone Michael calixsquaramide organocatalyst.

A novel upper-rim functionalized calix[4]squaramide organocatalyst bearing bis-squaramide and cyclohexanediamine scaffolds was designed and prepared to catalyze a serial of asym. Michael addition of 1,3-dicarbonyl compounds to α,β-unsaturated carbonyl compounds to afford chromenones, e.g., I in high yields (up to 99%) and good to excellent enantiomeric excesses (up to 99% ee). This method was also used for the synthesis of nitroalkanes II [R1 = Ph, 4-MeC6H4, 4-ClC6H4, etc.] via reaction of aryl nitroolefins with acetylacetone. The comparative experiments indicated that the cooperative effect between calixarenes cavitives and chiral catalytic centers on this calix[4]squaramide catalyst could promote these reactions.

Chinese Chemical Letters published new progress about 1,3-Dicarbonyl compounds Role: RCT (Reactant), RACT (Reactant or Reagent). 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Related Products of 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Nishiumi, Hideo; Kodama, Daisuke published the artcile< Prediction of CO2 solubility in glymes and ionic liquids using modified generalized BWR EoS>, Recommanded Product: (9Z,12Z)-Methyl octadeca-9,12-dienoate, the main research area is carbon dioxide glyme ionic liquid solubility dipole moment.

Glymes or ionic liquids are considered excellent solvents for carbon capture because they are insoluble in the gas phase during CO2 recovery. Hence, it is beneficial to predict the solubility of CO2 in these solvents to plan appropriate experiments for achieving carbon neutrality. In this study, Joback’s simple group contribution method (Joback and Reid, Chem. Eng. Commun. 57 (1987) 233-243) was used to predict the effectivity of ionic liquids or glymes toward CO2 dissolution Using this method, the fundamental and critical properties, such as critical temperature, critical pressure, critical molar volume, and acentric factor, were predicted. A binary interaction parameter, mij, which is necessary for calculating the solubility of CO2 in glyme or an ionic liquid, was also predicted using the critical volume ratio, Vc,i/Vc,CO2. Using the modified generalized BWR EoS, the value was best fitted at approx. 300 and 370 K. In general, the method proposed was effective in predicting the amount of CO2 that will dissolve in an unknown ionic liquid, which is essential for achieving carbon neutrality.

Fluid Phase Equilibria published new progress about Density. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Recommanded Product: (9Z,12Z)-Methyl octadeca-9,12-dienoate.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Morano, Federica; Raimondi, Alessandra; Pagani, Filippo; Lonardi, Sara; Salvatore, Lisa; Cremolini, Chiara; Murgioni, Sabina; Randon, Giovanni; Palermo, Federica; Antonuzzo, Lorenzo; Pella, Nicoletta; Racca, Patrizia; Prisciandaro, Michele; Niger, Monica; Corti, Francesca; Bergamo, Francesca; Zaniboni, Alberto; Ratti, Margherita; Palazzo, Michele; Cagnazzo, Celeste; Calegari, Maria Alessandra; Marmorino, Federica; Capone, Iolanda; Conca, Elena; Busico, Adele; Brich, Silvia; Tamborini, Elena; Perrone, Federica; Di Maio, Massimo; Milione, Massimo; Di Bartolomeo, Maria; de Braud, Filippo; Pietrantonio, Filippo published the artcile< Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O6-Methylguanine-DNA Methyltransferase-Silenced Metastatic Colorectal Cancer: The MAYA Trial>, Quality Control of 112-63-0, the main research area is .

This is a multicenter, single-arm phase II trial evaluating the efficacy and safety of an immune-sensitizing strategy with temozolomide priming followed by a combination of low-dose ipilimumab and nivolumab in patients with microsatellite-stable (MSS) and O6-methylguanine-DNA methyltransferase (MGMT)-silenced metastatic colorectal cancer (mCRC). Patients with pretreated mCRC were centrally prescreened for MSS status and MGMT silencing (ie, lack of MGMT expression by immunohistochem. plus MGMT methylation by pyrosequencing). Eligible patients received two priming cycles of oral temozolomide 150 mg/sqm once daily, days 1-5, once every 4 wk (first treatment part) followed, in absence of progression, by its combination with ipilimumab 1 mg/kg once every 8 wk and nivolumab 480 mg once every 4 wk (second treatment part). The primary end point was the 8-mo progression-free survival (PFS) rate calculated from enrollment in patients who started the second treatment part, with ≥ 4 out of 27 subjects progression-free by the 8-mo time point as decision rule. Among 716 prescreened patients, 204 (29%) were molecularly eligible and 135 started the first treatment part. Among these, 102 (76%) were discontinued because of death or disease progression on temozolomide priming, whereas 33 patients (24%) who achieved disease control started the second treatment part and represented the final study population. After a median follow-up of 23.1 mo (interquartile range, 14.9-24.6 mo), 8-mo PFS rate was 36%. Median PFS and overall survival were 7.0 and 18.4 mo, resp., and overall response rate was 45%. Grade 3-4 immune-related adverse events were skin rash (6%), colitis (3%), and hypophysitis (3%). No unexpected adverse events or treatment-related deaths were reported. The MAYA study provided proof-of-concept that a sequence of temozolomide priming followed by a combination of low-dose ipilimumab and nivolumab may induce durable clin. benefit in MSS and MGMT-silenced mCRC.

Journal of Clinical Oncology published new progress about 112-63-0. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Quality Control of 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Xuan, Yang; Wang, Huogang; Yung, Mingo Mh; Chen, Fushun; Chan, Wai-Sun; Chan, Yau-Sang; Tsui, Stephen Kw; Ngan, Hextan Ys; Chan, Karen K. L.; Chan, David W. published the artcile< SCD1/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells>, Electric Literature of 347174-05-4, the main research area is CAY10566 sc26196 cisplatin anticancer agent prognosis ferroptosis ovarian cancer; lipid desaturases; lipid metabolism; ovarian cancer; oxidative stress; peritoneal metastases.

Malignant ascites in peritoneal metastases is a lipid-enriched microenvironment and is frequently involved in the poor prognosis of epithelial ovarian cancer (EOC). However, the detailed mechanisms underlying ovarian cancer (OvCa) cells dictating their lipid metabolic activities in promoting tumor progression remain elusive. The omental conditioned medium (OCM) was established to imitate the omental or ascites microenvironment. Mass spectrometry, RT-qPCR, IHC, and western blot assays were applied to evaluate human fatty acid desaturases expressions and activities. Pharmaceutical inhibition and genetic ablation of SCD1/FADS2 were performed to observe the oncogenic capacities. RNA sequencing, lipid peroxidation, cellular iron, ROS, and Mito-Stress assays were applied to examine ferroptosis. OvCa patient-derived organoid and mouse model of peritoneal metastases were used to evaluate the combined effect of SCD1/FADS2 inhibitors with cisplatin. We found that two critical fatty acid desaturases, stearoyl-CoA desaturase-1 (SCD1) and acyl-CoA 6-desaturase (FADS2), were aberrantly upregulated, accelerating lipid metabolic activities and tumor aggressiveness of ascites-derived OvCa cells. Lipidomic anal. revealed that the elevation of unsaturated fatty acids (UFAs) was pos. associated with SCD1/FADS2 levels and the oncogenic capacities of OvCa cells. In contrast, pharmaceutical inhibition and genetic ablation of SCD1/FADS2 retarded tumor growth, cancer stem cell (CSC) formation and reduced platinum resistance. Inhibition of SCD1/FADS2 directly downregulated GPX4 and the GSH/GSSG ratio, causing disruption of the cellular/mitochondrial redox balance and subsequently, iron-mediated lipid peroxidation and mitochondrial dysfunction in ascites-derived OvCa cells. Combinational treatment with SCD1/FADS2 inhibitors and cisplatin synergistically repressed tumor cell dissemination, providing a promising chemotherapeutic strategy against EOC peritoneal metastases.

Theranostics published new progress about Antitumor agents. 347174-05-4 belongs to class esters-buliding-blocks, and the molecular formula is C15H22N2O2, Electric Literature of 347174-05-4.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Li, Sha; Xu, Jiayu; Luo, Xian; Yang, Wenhan; Yao, Changsheng published the artcile< Efficient N-heterocyclic carbene-catalyzed cascade synthesis of functionalized naphthopyranone>, Name: (9Z,12Z)-Methyl octadeca-9,12-dienoate, the main research area is heterocyclic carbene catalyst naphthopyranone cascade reaction preparation.

An efficient N-heterocyclic carbene(NHC)-catalyzed “”Michael-Michael-Lactonization”” cascade process involving chalcone derivatives and α-bromoenals for the syntheses of functionalized naphthopyranones was disclosed. This approach was qualified with good yields, readily available starting materials and mild reaction conditions.

Youji Huaxue published new progress about Lactonization. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Name: (9Z,12Z)-Methyl octadeca-9,12-dienoate.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Zhao, Haoyang; Jin, Kangyu; Jiang, Chaonan; Pan, Fen; Wu, Jing; Luan, Honglin; Zhao, Zhiyong; Chen, Jingkai; Mou, Tingting; Wang, Zheng; Lu, Jing; Lu, Shaojia; Hu, Shaohua; Xu, Yi; Huang, Manli published the artcile< A pilot exploration of multi-omics research of gut microbiome in major depressive disorders>, Reference of 112-63-0, the main research area is major depressive disorder gut microbiome metabolism immunity brain.

The pathophysiol. of major depressive disorder (MDD) remains obscure. Recently, the microbiota-gut-brain (MGB) axiss role in MDD has an increasing attention. However, the specific mechanism of the multi-level effects of gut microbiota on host metabolism, immunity, and brain structure is unclear. Multi-omics approaches based on the anal. of different body fluids and tissues using a variety of anal. platforms have the potential to provide a deeper understanding of MGB axis disorders. Therefore, the data of metagenomics, metabolomic, inflammatory factors, and MRI scanning are collected from the two groups including 24 drug-naive MDD patients and 26 healthy controls (HCs). Then, the correlation anal. is performed in all omics. The results confirmed that there are many markedly altered differences, such as elevated Actinobacteria abundance, plasma IL-1β concentration, lipid, vitamin, and carbohydrate metabolism disorder, and diminished gray matter volume (GMV) of inferior frontal gyrus (IFG) in the MDD patients. Notably, three kinds of discriminative bacteria, Ruminococcus bromii, Lactococcus chungangensis, and Streptococcus gallolyticus have an extensive correlation with metabolome, immunol., GMV, and clin. symptoms. All three microbiota are closely related to IL-1β and lipids (as an example, phosphoethanolamine (PEA)). Besides, Lactococcus chungangensis is neg. related to the GMV of left IFG. Overall, this study demonstrate that the effects of gut microbiome exert in MDD is multifactorial.

Translational Psychiatry published new progress about Acrobacter (lekithochrous). 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Reference of 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Chenna, Bala C.; Li, Linfeng; Mellott, Drake M.; Zhai, Xiang; Siqueira-Neto, Jair L.; Calvet Alvarez, Claudia; Bernatchez, Jean A.; Desormeaux, Emily; Alvarez Hernandez, Elizabeth; Gomez, Jana; McKerrow, James H.; Cruz-Reyes, Jorge; Meek, Thomas D. published the artcile< Peptidomimetic vinyl heterocyclic inhibitors of cruzain effect antitrypanosomal activity>, Safety of (9Z,12Z)-Methyl octadeca-9,12-dienoate, the main research area is peptidomimetic vinyl heterocyclic inhibitor cruzain preparation antitrypanosomal structure activity; PVHI cruzain substrate dipeptide enzyme kinetic mol docking; drug design computer assisted; Wittig reaction Horner Wadsworth Emmons amino acid peptide coupling.

Cruzain, an essential cysteine protease of the parasitic protozoan, Trypanosoma cruzi, is an important drug target for Chagas disease. We describe here a new series of reversible but time-dependent inhibitors of cruzain, composed of a dipeptide scaffold appended to vinyl heterocycles meant to provide replacements for the irreversible reactive “”warheads”” of vinyl sulfone inactivators of cruzain. Peptidomimetic vinyl heterocyclic inhibitors (PVHIs) containing Cbz-Phe-Phe/homoPhe scaffolds with vinyl-2-pyrimidine, vinyl-2-pyridine, and vinyl-2-(N-methyl)-pyridine groups conferred reversible, time-dependent inhibition of cruzain (Ki* = 0.1-0.4μM). These cruzain inhibitors exhibited moderate to excellent selectivity vs. human cathepsins B, L, and S and showed no apparent toxicity to human cells but were effective in cell cultures of Trypanosoma brucei brucei (EC50 = 1-15μM) and eliminated T. cruzi in infected murine cardiomyoblasts (EC50 = 5-8μM). PVHIs represent a new class of cruzain inhibitors that could progress to viable candidate compounds to treat Chagas disease and human sleeping sickness.

Journal of Medicinal Chemistry published new progress about Chagas disease. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Safety of (9Z,12Z)-Methyl octadeca-9,12-dienoate.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Derfuss, Tobias; Mehling, Matthias; Papadopoulou, Athina; Bar-Or, Amit; Cohen, Jeffrey A.; Kappos, Ludwig published the artcile< Advances in oral immunomodulating therapies in relapsing multiple sclerosis>, SDS of cas: 112-63-0, the main research area is review multiple sclerosis oral immunomodulating therapy.

A review. Although these immunomodulating therapies are all orally administered, and thus convenient for patients, they have different modes of action. These distinct mechanisms of action allow better adaptation of treatments according to individual comorbidities and offer different mechanisms of treatment such as inhibition of immune cell trafficking vs. immune cell depletion, thereby substantially expanding the available treatment options. Evobrutinib reduced MRI activity in a phase 2 trial, and a phase 3 trial is underway, in patients with relapsing multiple sclerosis. Diroximel fumarate is metabolised to monomethyl fumarate, the active metabolite of di-Me fumarate, reduces circulating lymphocytes and modifies the activation profile of monocytes, and is being tested in this disease with the aim to improve gastrointestinal tolerability. With new modes of action introduced to the treatment of multiple sclerosis, the question of how to select and sequence different treatments in individual patients arises. Balancing risks with the expected efficacy of disease-modifying therapies will still be key for treatment selection. This treatment scheme might lead to higher efficacy but also to new safety concerns. These sequential treatments were largely excluded in phase 2 and 3 trials; therefore, monitoring both short-term and long-term effects of sequential disease-modifying therapies in phase 4 studies, cohort studies, and registries will be necessary.

Lancet Neurology published new progress about Brain. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, SDS of cas: 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Wang, Min-Chen; Furukawa, Fumiya; Wang, Ching-Wei; Peng, Hui-Wen; Lin, Ching-Chun; Lin, Tzu-Hao; Tseng, Yung-Che published the artcile< Multigenerational inspections of environmental thermal perturbations promote metabolic trade-offs in developmental stages of tropical fish>, Related Products of 112-63-0, the main research area is Tilapia development citrate metabolite global warming environmental thermal perturbation; Dynamic visualization; Energy trade-off; Hypothermic experience; Multigeneration; Transgenerational plasticity.

Global warming both reduces global temperature variance and increases the frequency of extreme weather events. In response to these ambient perturbations, animals may be subject to trans- or intra-generational phenotype modifications that help to maintain homeostasis and fitness. Here, we show how temperature-associated transgenerational plasticity in tilapia affects metabolic trade-offs during developmental stages under a global warming scenario. Tropical tilapia reared at a stable temperature of 27°C for a decade were divided into two temperature-experience groups for four generations of breeding. Each generation of one group was exposed to a single 15°C cold-shock experience during its lifetime (cold-experienced CE group), and the other group was kept stably at 27°C throughout their lifetimes (cold-naive CN group). The offspring at early life stages from the CE and CN tilapia were then assessed by metabolomics-based profiling, and the results implied that parental cold-experience might affect energy provision during reproduction Furthermore, at early life stages, progeny may be endowed with metabolic traits that help the animals cope with ambient temperature perturbations. This study also applied the feature rescaling and Uniform Manifold Approximation and Projection (UMAP) to visualize metabolic dynamics, and the result could effectively decompose the complex omic-based datasets to represent the energy trade-off variability. For example, the carbohydrate to free amino acid conversion and enhanced compensatory features appeared to be hypothermic-responsive traits. These multigenerational metabolic effects suggest that the tropical ectothermic tilapia may exhibit transgenerational phenotype plasticity, which could optimize energy allocation under ambient temperature challenges. Knowledge about such metabolism-related transgenerational plasticity effects in ectothermic aquatic species may allow us to better predict how adaptive mechanisms will affect fish populations in a climate with narrow temperature variation and frequent extreme weather events.

Environmental Pollution (Oxford, United Kingdom) published new progress about Appetite. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Related Products of 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics